Designing protocols to maintain a trial's validity while enabling seriously ill and informed participants to receive both SOC and investigational products will help to improve patient participation in oncology clinical trials.
Marylyn Donahue
Advertisement
Articles by Marylyn Donahue
Five industry veterans discuss the growth, impact, and evolution of outsourcing.
Advertisement
Latest Updated Articles
Question and Answer with Outsourcing LeadersPublished: March 1st 2011 | Updated:
- Do Oncology Clinical Trials Need PR?
Published: November 6th 2014 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Integrating AI Across Legacy Clinical Trial Systems
2
Reimagining Clinical Operations Through Artificial Intelligence
3
Balancing Human Oversight and Automation in AI-Driven Trials
4
Preparation Tips to Minimize Impact of Regulatory Inspections for IRT Systems
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
